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Wild Meripilus giganteus Karst belongs to the order Polyporales, in which some members are known to
possess a wide range of pharmacological properties. M. giganteus showed to be rich in carbohydrates
(74.49 g/100 g) and proteins (15.94 g/100 g), presenting low fat content (1.51 g/100 g). Chemical
composition was determined by using chromatographic techniques. Also, various bioactive compounds
were detected including all four tocopherol isoforms with d- and g-tocopherols being predominant
(123.35 and 77.80 mg/100 g, respectively); ﬁve organic acids (oxalic, malic, quinic, citric and fumaric
acids) with predominant malic acid (3.17 g/100 g); and three phenolic acids and related compounds (p-
hydroxybenzoic, p-coumaric and cinnamic acids; 1010, 2420 and 340 mg/100 g, respectively).M. giganteus
methanolic extract exhibited antioxidant activity tested by ﬁve different assays with the strongest po-
tential in TBARS assay (EC50 0.31 mg/mL); and antimicrobial activities (MIC/MBC 0.0125e5 mg/mL; MIC/
MFC 0.025e0.4 mg/mL). Furthermore, treatment of cervical carcinoma cell line (HeLa) led to reduction in
cell's viability in MTT assay (IC50 0.41 mg/mL after 48 h), induced process of apoptosis and inhibited cell's
migration in vitro. The analysed extract was not toxic for zebraﬁsh embryos (at 0.5 mg/mL), indicating its
biosafety and potential application as a dietary supplement in chemoprevention.
© 2017 Elsevier Ltd. All rights reserved.1. Introduction
Besides their high nutritional value (Kalac, 2013), mushrooms
possess a wide variety of beneﬁcial effects to human health, with
special emphasis on pharmacological properties such as antioxi-
dant (Ferreira, Barros, & Abreu, 2009), antimicrobial (Alves et al.,
2013) and antitumor (Popovic, Zivkovic, Davidovic, Stevanovic, &
Stojkovic, 2013) activities. Among the bioactive constituents inrs (M. Stevanovic), iferreira@
ic).medicinal and edible mushrooms, tocopherols, fatty acids, organic
acids, polyphenols, polysacharides and proteins are the most
frequently reported. Bioactivity of tocopherols includes antioxidant
capacity (Ferreira et al., 2009) that confers ability to prevent dis-
eases correlated with increased formation of free radicals and
oxidative stress. Also, polyunsaturated fatty acids (PUFAs) seem to
be endogenous mediators for cell signaling, being involved in the
regulation of gene expression and other biological processes
(Choque, Catheline, Rioux,& Legrand, 2014). Furthermore, phenolic
compounds are known to exert multiple biological effects,
including antioxidant, antitumor, antimutagenic and antibacterial
properties (Kancheva & Kasaikina, 2013).
Reactions leading to the production of free radicals namely,
reactive oxigen species (ROS), reactive nitrosative species (RNS) and
reactive sulphur species (RSS) have been linked to many severe
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antioxidants from natural origin, being able to neutralize free
radicals, is one of the major concerns in the ﬁeld of cancer che-
moprevention. In addition, more than 15% of malignancies world-
wide have been related to an infectious cause (Mager, 2006).
Although there are effective ways and reliable drugs to treat mi-
crobial infections, some bacteria and fungi develop mechanisms to
overcome the effects of commercial antimicrobial agents, mostly
due to their misuse. Proper treatment of microbial infections is
leading to lower cancer occurrence and this should inﬂuence the
well-being of human population (Assaf et al., 2013). Additionally,
mycotherapy of cancer is emerging as a rapidly growing and
promising discipline that involves the study of cancer chemo-
preventive and anticancer properties of mushrooms extracts and
their bioactive compounds (Popovic et al., 2013).
Meripilus giganteus Karst. is a wild growing basidiomycete with
an edible fruiting body, belonging to the family Meripilaceae. It is a
parasitic species on trees, being also characterized as saprobic. It is
frequently found on Quercus and Fagus species, but it can also be
found on some hardwoods and coniferous species. M. giganteus is
mainly distributed in northern hemisphere, in Europe, Turkey, Iran
and northern Asia (Schmidt, 2006). So far, reports on chemical
composition of M. giganteus growing wild in Serbia, as well as on
bioactive properties of its methanolic extract are very scarce
(Karaman, Jovin, Malbasa, Matavuly, & Popovic, 2010; Karaman,
Kaisarevic, Somborski, Kebert, & Matavulj, 2009). The present
study aims to characterize the chemical composition of
M. giganteus and to evaluate its biological properties namely,
antioxidant potential, antimicrobial activity and the effect on can-
cer cell's viability, apoptosis and migration in vitro. Finally, its
toxicity was evaluated on zebraﬁsh.
2. Materials and methods
2.1. Samples
The samples of wild growing Meripilus giganteus Karst. were
collected in Bojcinska forest, Belgrade, Serbia, in autumn 2012, and
authenticated by Dr. Jasmina Glamoclija (Institute for Biological
Research). A voucher specimen was deposited at the Fungal
Collection Unit of the Mycological Laboratory, Department for Plant
Physiology, Institute for Biological Research “Sinisa Stankovic”,
Belgrade, Serbia, under the numberMg 1812012. The samples were
lyophilized (LH Leybold, Lyovac GT2, Frenkendorf), reduced to a ﬁne
dried powder (20 mesh) and stored in a desiccator, protected from
light, until further analysis.
2.2. Standards and reagents
Acetonitrile 99.9%, n-hexane 95% and ethyl acetate 99.8% were
of HPLC grade from Fisher Scientiﬁc (Lisbon, Portugal). The fatty
acids methyl ester (FAME) reference standard mixture 37 (standard
47885-U) was purchased from Sigma (St. Louis, MO, USA), as also
were other individual fatty acid isomers, trolox (6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid), tocopherol and sugar
standards. Phenolic compound standards were from Extrasynthese
(Genay, France). Racemic tocol, 50 mg/mL, was purchased from
Matreya (Pleasant Gap, PA, USA). 2,2-Diphenyl-1- picrylhydrazyl
(DPPH) was obtained from Alfa Aesar (Ward Hill, MA, USA). Dul-
becco's modiﬁed Eagle's medium (DMEM), fetal bovine serum (FBS)
and MEM non-essential amino acids (NEAA) were obtained from
Invitrogen (NY, USA). 3-(4,5-Dimethylthiazol-2yl)-2,5-
diphenyltetrazolium bromide (MTT), paraformaldehyde (PFA) and
dimethylsulfoxide (DMSO) were from Merck (KGaA, Germany).
40,6-Diamidino-2-phenylindole dihydrochloride (DAPI) andpropidium iodide (PI) were obtained from Sigma (St. Louis, MO,
USA) and doxorubicin from Pﬁzer Inc (NY, USA). APOPTEST™-FITC
kit was obtained from Dako (Agilent Technologies Inc., Denmark).
MuellereHinton agar (MH) andmalt agar (MA) were obtained from
the Institute of Immunology and Virology, Torlak (Belgrade, Serbia).
Water was treated in a Milli-Q water puriﬁcation system (TGI Pure
Water Systems, Greenville, SC, USA).
2.3. Preparation of the M. giganteus methanolic extract
Samples (~5 g) were extracted by stirring with 150 mL of
methanol (25 C at 150 rpm) for 1 h and subsequently ﬁltered
through Whatman No. 4 paper. The residue was then extracted
with an additional portion of methanol. The combined methanolic
extracts were evaporated under reduced pressure (rotary evapo-
rator Büchi R-210; Flawil, Switzerland) to dryness (Heleno, Barros,
Sousa, Martins, & Ferreira, 2010). The extract was redissolved in i)
methanol (ﬁnal concentration 20 mg/mL) for antioxidant activity
assays, ii) 30% EtOH (ﬁnal concentration 1.5 mg/mL) for antimi-
crobial activity assays and for cytotoxic activity evaluation (80 mg/
mL ﬁnal concentration). The ﬁnal solutions were further diluted to
different concentrations to be submitted to distinct bioactivity
evaluation in vitro assays. The results were expressed in i) EC50
values (sample concentration providing 50% of antioxidant activity
or 0.5 of absorbance in the reducing power assay) for antioxidant
activity; ii) MIC (Minimum inhibitory concentration) andMBC/MFC
(Minimum bactericidal concentration/Minimum fungicidal con-
centration) values for in vitro antimicrobial activity iii) IC50 value
(sample concentration providing 50% inhibition of cell growth in
MTT test) for cytotoxicity assay.
2.4. Chemical characterization of the M. giganteus methanolic
extract - bioactive compounds
Tocopherols were determined following a procedure previously
described by the authors (Heleno et al., 2010) using HPLC-
ﬂuorescence. The compounds were identiﬁed by chromatographic
comparisons with authentic standards. Quantiﬁcation was based
on the ﬂuorescence signal response of each standard, using the IS
(tocol) method and by using calibration curves obtained from
commercial standards of each compound: a-tocopherol
(y ¼ 1.295x; R2 ¼ 0.991); b-tocopherol (y ¼ 0.396x; R2 ¼ 0.992); g-
tocopherol (y ¼ 0.567x; R2 ¼ 0.991); d-tocopherol (y ¼ 0.678x;
R2 ¼ 0.992). The results were expressed in mg per 100 g of dry
weight (dw). Organic acids were determined by ultrafast liquid
chromatography coupled to a photodiode array detector (UFLC-
PAD), following a procedure previously described by the authors
(Barros, Pereira, & Ferreira, 2013). The organic acids found were
quantiﬁed by comparison of the area of their peaks recorded at
215 nm with calibration curves obtained from commercial stan-
dards of each compound: oxalic acid (y ¼ 1  107xþ96178;
R2 ¼ 0.999); quinic acid (y ¼ 601768xþ8853.2; R2 ¼ 1); malic acid
(y ¼ 952269xþ17803; R2 ¼ 1) and fumaric acid
(y ¼ 172760xþ52193; R2 ¼ 0.999. The results were expressed in g
per 100 g of dry mushroom (dw). Phenolic compounds were
determined by the samemethodology using 280 nm and 370 nm as
preferred wavelengths, according to a procedure previously
described by the authors (Barros, Due~nas, Ferreira, Baptista, &
Santos-Buelga, 2009). The phenolic compounds were character-
ized according to their UV and mass spectra and retention times,
and comparison with authentic standards when available. For the
quantitative analysis of phenolic compounds, a calibration curve
was obtained by injection of known concentrations (5e80 mg/mL)
of different standards compounds: p-hydroxybenzoic acid
(y ¼ 16420xþ12914; R2 ¼ 0.9999); p-coumaric acid
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(y ¼ 86366xþ88451; R2 ¼ 0.999). The results were expressed as mg
per 100 g of dry weight (dw).
2.5. Antioxidant activity
DPPH radical-scavenging activity was evaluated by using an
ELX800 microplate reader (Bio-Tek Instruments, Inc; Winooski, VT,
USA), and calculated as a percentage of DPPH discolouration using
the formula: [(ADPPH-AS)/ADPPH]  100, where AS is the absorbance
of the solution containing the sample at 515 nm, and ADPPH is the
absorbance of the DPPH solution. Reducing powerwas evaluated by
two different assays: Ferricyanide/Prussian blue assay, which de-
termines the capacity to convert Fe3þ into Fe2þ, measuring the
absorbance at 690 nm in the microplate reader mentioned above;
Folin-Ciocalteu assay: the colour development was measured at
765 nm (Analytikjena spectrophotometer; Jena, Germany). Gallic
acid was used to obtain the standard curve and the reduction of
Folin-Ciocalteu reagent by the samples was expressed as mg of
gallic acid equivalents (GAE) per g of extract (Heleno et al., 2010).
Inhibition of b-carotene bleaching was evaluated though the b-
carotene/linoleate assay; the neutralization of linoleate free radi-
cals avoids b-carotene bleaching, measured at 470 nm and calcu-
lated by the formula: b-carotene absorbance after 2 h of assay/
initial absorbance)  100 (Heleno et al., 2010). Lipid peroxidation
inhibition in porcine (Sus scrofa) brain homogenates was evaluated
by the decreasing in thiobarbituric acid reactive substances
(TBARS); the colour intensity of the malondialdehyde-
thiobarbituric acid (MDA-TBA) was measured by its absorbance at
532 nm; the inhibition ratio (%) was calculated using the following
formula: [(A - B)/A] 100%, where A and B were the absorbances of
the control and the sample solution, respectively (Heleno et al.,
2010). Trolox was used as a positive control in all of the antioxi-
dant assays.
2.6. Antimicrobial properties
The following Gram-negative bacteria were used: Escherichia
coli (ATCC 35210), Pseudomonas aeruginosa (ATCC 27853), Salmo-
nella typhimurium (ATCC 13311), Enterobacter cloacae (ATCC 35030)
and the following Gram-positive bacteria: Staphylococcus aureus
(ATCC 6538), Bacillus cereus (clinical isolate), Micrococcus ﬂavus
(ATCC 10240), and Listeria monocytogenes (NCTC 7973).
For the antifungal bioassays, microfungi were used: Aspergillus
fumigatus (1022), Aspergillus ochraceus (ATCC 12066), Aspergillus
versicolor (ATCC 11730), Aspergillus niger (ATCC 6275), Penicillium
funiculosum (ATCC 36839), Penicillium ochrochloron (ATCC 9112),
Trichoderma viride (IAM 5061), and Penicillium aurantiogriseum
(food isolate). The organisms were obtained from the Mycological
Laboratory, Department of Plant Physiology, Institute for Biological
Research “Sinisa Stankovic”, Belgrade, Serbia.
In order to investigate the antimicrobial activity of the
M. giganteus methanolic extract, a modiﬁed microdilution tech-
nique was used (CLSI, 2009). Minimum inhibitory concentration
(MIC) determinations were performed by a serial dilution tech-
nique using 96-well microtiter plates. The minimum bactericidal
concentrations (MBCs) and minimum fungicidal concentrations
(MFCs) were determined by serial subcultivation of a 2 mL sample
into microtiter plates containing 100 mL of broth per well and
further incubation for 48 h at 37 C or 72 h at 28 C. The lowest
concentration with no visible growth was deﬁned as MBC/MFC,
respectively, indicating 99.5% killing of the original inoculum.
Streptomycin (streptomycin sulfate (ICN-Galenika, Belgrade,
Serbia) and ampicillin (Panfarma, Belgrade, Serbia) were used as
positive controls in antibacterial assay, while commercialfungicides, bifonazole (Srbolek, Belgrade, Serbia) and ketoconazole
(Zorkapharma, Sabac, Serbia), were used as positive controls in
antifungal tests (1 mg/ml in sterile physiological saline). 30% EtOH
was used as a negative control.
2.7. Evaluation of cytotoxicity by MTT assay
Human cervical cancer cell line HeLa and human lung ﬁbro-
blasts MRC-5 were cultured in DMEM supplemented with 1% NEAA
and 10% FBS at 37 C in a humidiﬁed incubator with 5% CO2. Cell
viability was determined by the colorimetric MTT assay. Brieﬂy,
24 h before treatment 4  103 HeLa cells/well and 104 MRC-5 cells/
well were seeded in 96-well plates. Cells were then treated for 24
and 48 h with various concentrations of M. giganteus methanolic
extract (prepared by dilution from the inicial stock solution, 80 mg/
mL) or doxorubicin as a positive reference compound. Relative cell
viability was obtained by measuring the absorbance at 550 nm in a
Multiscan RC microplate reader (Thermo Labsystems, Helsinki,
Finland). Concentrations that caused 50% (IC50) or 80% (IC80) of
inhibition of cells growth after 24 and 48 h of treatment were
calculated based on their survival rate compared with control cells
treated with vehicle only (30% ethanol).
2.8. Double DAPI and PI staining of live cells
Control cells and cells treated with IC50 and IC80 concentrations
of extract were grown for 24 and 48 h on coverslips in 6-well plates.
After washing three times in phosphate buffered saline (PBS), the
cells were incubated in PBS containing 1 mg/mL of DAPI and 5 mg/mL
of PI for 10 min at RT. After staining, cells were washed three times
in PBS and ﬁxed with 4% PFA for 15min. Cells were examined under
the Zeiss Axiovert inverted ﬂuorescent microscope (Carl Zeiss
Foundation, Oberkochen, Germany) equipped with AxioVision4.8
software, using 365/550 nm excitation; the ﬂuorescence emission
was measured at 445 nm for DAPI and 605 nm for PI with a 20
objective.
2.9. Detection of apoptosis by a double staining method with
Annexin V-FITC and PI
Apoptosis assays were conducted using the APOPTEST™-FITC
kit according to the manufacturer's instructions. Brieﬂy, control
cells (treated with vehicle only) and cells treated with IC50 con-
centration of extract for 48 h were washed twice with cold PBS,
resuspended in 1  Binding Buffer at a concentration of ~
1  106 cells/mL and Annexin V-FITC and PI were added at the ﬁnal
concentrations of 25 ng/mL and 2.5 mg/mL, respectively. The cells
were gently mixed, incubated for 10 min in the dark at RT, and
immediately analyzed (within 1 h) by Partec CyFlow® Space (Partec
GmbH, Münster, Germany). The ﬂow cytometer collected 100,000
events and analysis was performed using Flomax Software ©
Version 2.9.
2.10. Wound-scratch migration assay
3  105 cells were plated in 35 mm dish, grown to conﬂuence
and treated with IC50 (24 h) concentration ofM. giganteus extract in
serum reduced conditions (1% FCS in DMEM) for 12 h before wound
was made. Conﬂuent cell monolayer was scratched with a 200 ml
tip, washed with serum-free medium to remove detached cells and
ﬁnally fresh medium containing 1% FCS and M. giganteus extract
was added. Cell migration into the wounded area was monitored
using DM IL LED InvertedMicroscope (Leica Microsystems,Wetzlar,
Germany) and closure of the gap distance was quantiﬁed using
Leica Application Suite V4.3.0.
Fig. 1. Bioactive compounds identiﬁed in M. giganteus extract. A. Individual tocoph-
erols chromatogram: 1-a-tocopherol; 2- BHT; 3- b-tocopherol; 4- g-tocopherol; 5- d-
tocopherol; 6-tocol (IS). B. Individual organic acids chromatogram: 1- oxalic acid; 2-
quinic acid; 3- malic acid; 4- citric acid; 5- fumaric acid. C. Individual phenolic com-
pounds chromatogram: 1- p-hydroxybenzoic acid; 2- p-coumaric acid; 3- cinnamic
acid. MP- Mobile phase.
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Assay is described in detail in Supplementary material.
2.12. Statistical analysis
Three samples were used and all the assays were carried out in
triplicate. The results are expressed as mean values ± standard
deviation (SD) or standard error mean (SEM). The results were
analyzed using one-way analysis of variance (ANOVA) followed by
Tukey's HSD test with a¼ 0.05 or Student's t-test. This analysis was
carried out using SPSS 22.0 program.
3. Results and discussion
3.1. Chemical composition of M. giganteus methanolic extract-
bioactive compounds
Bioactive compounds (tocopherols, organic and phenolic acids)
identiﬁed in M. giganteus are presented in Table 1. All tocopherol
isoforms were detected, but d- and g-tocopherols were the pre-
dominant isoforms (Table 1 and Fig. 1A). On the other hand, b- and
a-tocopherols were found at lower levels (Table 1). The most
suitable sources of antioxidants, such as tocopherols, are provided
by our diet, more than by antioxidant supplements (pills or tablets)
(Bjelakovic, Nikolova, & Gluud, 2014). M. giganteus represents a
food source regarding intake of antioxidant tocopherols and to the
best of our knowledge, tocopherols composition in this species was
not previously reported in literature.
Quantitative values of organic acids identiﬁed in M. giganteus
are given in Table 1 and its proﬁle is represented in Fig. 1B. Malic
acid, a dicarboxylic acid occurring naturally in all fruits, many
vegetables and mushrooms, was the predominant organic acid,
which was also observed for other mushroom species (Barros et al.,
2013). Oxalic, citric, quinic and fumaric acids were also identiﬁed
and quantiﬁed. Health-beneﬁcial effects and bioactive properties of
some organic acids are well-known and include antimicrobial,
antioxidant and acidifying properties. Our results are in accordance
to those published for other mushroom species (Barros et al., 2013).
Phenolic acids proﬁle was provided in Fig. 1C p-Coumaric acid
was the most abundant phenolic component identiﬁed in
M. giganteus, while p-hydroxybenzoic and cinnamic acids were
found at lower levels (Table 1). A previous study performed by
Karaman et al. (2010) reported gallic (675 mg/g) and protocatechuic
(279 mg/g) acids as the only phenolic compounds in M. giganteus,
while p-coumaric acid was not detected. The observed differences
might be attributed to different extraction methodologies or
different maturity stages of fruiting bodies, among other factors.
Nutritional value, sugars composition and fatty acids proﬁle are
presented in Supplementary material.
3.2. In vitro analysis of bioactive properties
In order to analyze bioactive properties of M. giganteus meth-
anolic extract, we have investigated antioxidant activity,Table 1
Bioactive composition of M. giganteus on dry weight basis (mean ± SD).
Phenolic acids (mg/100 g) Tocopherols (mg/100 g) Organic acids (g/100 g)
p-Hydroxybenzoic acid 1010 ± 110 a-tocopherol 3.58 ± 0.39 Oxalic acid 1.32 ± 0.02
p-Coumaric acid 2420 ± 590 b-tocopherol 9.05 ± 0.13 Quinic acid 0.48 ± 0.03
Cinnamic acid 340 ± 40 g-tocopherol 77.80 ± 0.66 Malic acid 3.17 ± 0.01
Total phenolic acids* 3430 ± 470 d-tocopherol 123.35 ± 40.11 Citric acid 0.77 ± 0.01
Total tocopherols 213.78 ± 40.52 Fumaric acid 0.16 ± 0.00
Total organic acids 5.90 ± 0.03
Table 2
Antioxidant properties of the M. giganteus methanolic extract (mean ± SD).
Antioxidant activity tests Extract
Folin- Ciocalteu assay
(mg GAE/g extract)
58.20 ± 5.10
Ferricyanide/Prussian blue assay (EC50;mg/mL) 0.83 ± 0.01
DPPH scavenging activity
(EC50;mg/mL)
2.08 ± 0.06
b-Carotene/linoleate assay
(EC50;mg/mL)
2.14 ± 0.12
TBARS assay
(EC50;mg/mL)
0.31 ± 0.02
Concerning the Folin-Ciocalteu assay, higher values mean higher reducing power;
for the other assays, the results are presented in EC50 values, whatmeans that higher
values correspond to lower reducing power or antioxidant potential. EC50: Extract
concentration corresponding to 50% of antioxidant activity or 0.5 of absorbance for
the Ferricyanide/Prussian blue assay. Trolox EC50 values: 41 mg/mL (Ferricyanide/
Prussian blue assay), 42 mg/mL (DPPH scavenging activity), 18 mg/mL (b-Carotene/
linoleate assay) and 23 mg/mL (TBARS assay).
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apoptosis and migration in vitro. Finally, toxicity testing of
M. giganteus methanolic extract was performed on zebraﬁsh em-
bryos and these results are presented in Supplementary material.
3.2.1. The antioxidant activity
Since natural matrices with antioxidant activity important for
the discovery of novel cancer chemopreventive and chemothera-
peutic agents, we have analyzed the antioxidant activity of
M. giganteus methanolic extract by ﬁve different in vitro assaysTable 3
In vitro antimicrobial activity of M. giganteus extract.
Bacteria M. giganteus
MIC/MBC (mg/mL)
Staphylococcus aureus 0.0125 ± 0.0008a
0.035 ± 0.002a
Bacillus cereus 0.0125 ± 0.0008a
0.035 ± 0.002a
Micrococcus ﬂavus 0.60 ± 0.03c
1.25 ± 0.080b
Listeria monocytogenes 0.30 ± 0.000b
0.60 ± 0.010c
Pseudomonas aeruginosa 0.60 ± 0.020b
1.25 ± 0.020b
Salmonella typhimurium 0.025 ± 0.002a
0.035 ± 0.002a
Escherichia coli 0.15 ± 0.007a
0.60 ± 0.000a
Enterobacter cloacae 2.50 ± 0.070b
5.00 ± 0.000c
Fungi M. giganteus
MIC/MFC (mg/mL)
Aspergillus fumigatus 0.10 ± 0.010a
0.20 ± 0.000a
Aspergillus versicolor 0.025 ± 0.000a
0.050 ± 0.002a
Aspergillus ochraceus 0.20 ± 0.010a
0.40 ± 0.010a
Aspergillus niger 0.30 ± 0.010c
0.40 ± 0.000a
Trichoderma viride 0.05 ± 0.002a
0.20 ± 0.010a
Penicillium funiculosum 0.025 ± 0.000a
0.400 ± 0.010a
Penicillium ochrochloron 0.20 ± 0.000a
0.40 ± 0.020a
Penicillium aurantiogriseum 0.20 ± 0.010a
0.40 ± 0.000a
In each row different letters mean signiﬁcant differences (p < 0.05).(Table 2).
Total phenolics content in the methanolic extract was 58.20 mg
GAE/g of extract which is higher than the one reported by Karaman
et al. (2010) (5.11 mg of chlorogenic acid equivalents/g of dry
weight ofM. giganteus). The obtained difference might be related to
the different extraction methods used. Lipid peroxidation inhibi-
tion, evaluated by the decreasing in TBARS formation, gave the best
result with EC50 value of 0.31 mg/mL. For Ferricyanide/Prussian
blue assay, EC50 value was 0.83 mg/mL. On the other hand, DPPH
scavenging activity and inhibition of b-carotene bleaching gave
slightly higher results with EC50 values of 2.08 mg/mL and 2.14 mg/
mL, respectively. DPPH scavenging activity of M. giganteus 70%
methanolic extract was previously evaluated and the EC50 value
was 0.155 mg/mL (Karaman et al., 2010). In the present study, the
EC50 DPPH scavenging activity value was signiﬁcantly higher
compared to the mentioned report and this difference might be
explained by the different extraction conditions and drying pro-
cesses applied to mushrooms (e.g. drying in the oven at 50 C). As
far as we know, this is the ﬁrst study reporting antioxidant activity
of pure methanolic extract of M. giganteus. The observed antioxi-
dant activity may be related to the presence of phenolic acids and
tocopherols, as generalized for other mushroom species (Ferreira
et al., 2009).3.2.2. Antimicrobial properties
Antibacterial and antifungal activity of the M. giganteus extract
was assessed by microdilution methods, and the results are pre-
sented as MIC andMBC/MFC in Table 3. The most sensitive bacterial
species to M. giganteus methanolic extract were S. aureus andStreptomycin
MIC/MBC (mg/mL)
Ampicillin
MIC/MBC (mg/mL)
0.04 ± 0.002b
0.09 ± 0.003b
0.25 ± 0.000c
0.37 ± 0.0100c
0.09 ± 0.003b
0.17 ± 0.0100b
0.25 ± 0.0100c
0.37 ± 0.007c
0.17 ± 0.010a
0.34 ± 0.010a
0.25 ± 0.0200b
0.37 ± 0.000a
0.17 ± 0.010a
0.34 ± 0.010a
0.37 ± 0.010c
0.49 ± 0.010b
0.17 ± 0.010a
0.34 ± 0.000a
0.74 ± 0.000c
1.24 ± 0.010b
0.17 ± 0.010b
0.34 ± 0.010b
0.37 ± 0.010c
0.49 ± 0.020c
0.17 ± 0.007b
0.34 ± 0.010b
0.25 ± 0.000c
0.49 ± 0.020c
0.26 ± 0.000a
0.52 ± 0.007a
0.37 ± 0.010a
0.74 ± 0.010b
Bifonazole
MIC/MFC (mg/mL)
Ketoconazole
MIC/MFC (mg/mL)
0.15 ± 0.000b
0.20 ± 0.020a
0.20 ± 0.010c
0.50 ± 0.020b
0.10 ± 0.010b
0.20 ± 0.000b
0.20 ± 0.020c
0.50 ± 0.010c
0.15 ± 0.007a
0.20 ± 0.020a
1.50 ± 0.070b
2.00 ± 0.100b
0.15 ± 0.000a
0.20 ± 0.010b
0.20 ± 0.010b
0.50 ± 0.020c
0.15 ± 0.007a
0.20 ± 0.000a
1.00 ± 0.070b
1.00 ± 0.100b
0.20 ± 0.010b
0.25 ± 0.000b
0.20 ± 0.010b
0.50 ± 0.010c
0.20 ± 0.010a
0.25 ± 0.007b
2.50 ± 0.070b
3.50 ± 0.070c
0.10 ± 0.010b
0.20 ± 0.010b
0.20 ± 0.000b
0.30 ± 0.020c
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mL). E. cloacae strain was the most resistant to the effect of
M. giganteus extract with MIC of 2.50 mg/mL and MBC of 5.00 mg/
mL. It should be noted that the most sensitive bacterial strains wereTable 4
Cytotoxic activity of M. giganteus methanolic extract (mean ± SD) on HeLa and MRC-5 ce
Extract (mg/mL)
24 h 48 h
HeLa IC50 0.72 ± 0.27b 0.41
IC80 1.32 ± 0.23b 0.80
MRC-5 IC50 >1.6 >1.6
IC80 na na
The results are expressed as IC50 and IC80 values corresponding to the extract/compoun
treatment, respectively. Doxorubicin was used as a positive reference compound. Differe
24 h and 48 h of treatment, respectively (p  0.05). Na-not acquired.
Fig. 2. M. giganteus methanolic extract induces apoptosis of HeLa cells. A) Representative co
PI staining. Cells were treated with IC50 and IC80 concentrations ofM. giganteus extract for 24
normal nuclei, (EA) live cells with apoptotic nuclei showing chromatin condensation, (LA)
Annexin-FITC staining and propidium iodide accumulation after treatment of HeLa cells w
concentrations (T) of the extract for 48 h. Presented panels are from one representative exp
expressed as mean ± SEM of three independent experiments. Values of P < 0.01 are presenGram positive. Although,M. ﬂavus (Gram positive) and P. aeruginosa
(Gram negative) had the same inhibitory and bactericidal values
(0.60 mg/mL and 1.25 mg/mL), it might be suggested that the
antimicrobial activity is dependent on bacterial species used. Thell lines.
Doxorubicin (mg/mL)
24 h 48 h
± 0.08b 0.0069 ± 0.0006a 0.0027 ± 0.0003a
± 0.04b 0.0091 ± 0.0010a 0.0039 ± 0.0007a
0.0059 ± 0.0012 0.0025 ± 0.0004
0.0091 ± 0.0022 0.0046 ± 0.0005
d concentration, which inhibited 50% and 80% of cell growth after 24 and 48 h of
nt letters (a, b) mean signiﬁcant differences between extract and doxorubicin after
mposite images showing morphological changes of HeLa cells detected with dual DAPI/
and 48 h and imaged by ﬂuorescence microscope. Arrows indicate (L) viable cells with
dead cells in late apoptosis/necrosis. Scale bar e 50 mm. B) Flow cytometry analysis of
ith M. giganteus methanolic extract. Cells were treated either with vehicle (C) or IC50
eriment that was performed three times with similar results C) In histogram values are
ted by asterisks.
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S. aureus ¼ B. cereus > S. typhimurium > E. coli > L. monocytogenes >
M. ﬂavus ¼ P. aeruginosa > E. cloacae. Karaman et al. (2010), even
though applying different method, also found S. aureus strain as the
most sensitive to the antimicrobial action of M. giganteus.
Regarding antifungal activity, A. versicolor and P. funiculosum
were themost susceptible micromycetes withMICs of 0.025mg/mL
and MFCs of 0.050 mg/mL. A. niger was the most resistant strain
withMIC of 0.30mg/mL andMFC of 0.40mg/mL. Antifungal activity
of the tested sample decreased in order:
A. versicolor ¼ P. funiculosum > T. viride > A. fumigatus >
A. ochraceus ¼ P. ochrochloron ¼ P. aurantiogriseum > A. niger. In
general, fungi were more sensitive than bacteria to the effect of
M. giganteus extract. To the best of our knowledge, no previous
studies reported antifungal activity of M. giganteus. Standard anti-
biotics (streptomycin and ampicillin) and antimycotics (bifonazole
and ketoconazole) were used as positive controls, but comparison
with M. giganteus extract should be avoided, since the extract
presents a mixture of compounds in which the concentration of
each bioactive compound is much lower than the MIC. Antimicro-
bial activity could be related to the presence of the phenolic acidsFig. 3. Effect of M. giganteus extract on migration of HeLa cells (wound-scratch migration
M. giganteus extract or vehicle, by measuring the difference in gap closure where gap widt
independent experiments. Value of P < 0.001 is presented by an asterisk.identiﬁed in the extract that also show antimicrobial properties
against bacteria and fungi (Heleno et al., 2013).
3.2.3. Evaluation of cytotoxic properties on HeLa cells
The effect ofM. giganteusmethanolic extract on the proliferation
and viability of HeLa cells was assessed using MTT assay. A dose-
dependent growth inhibition was observed in HeLa cell line after
treatment with the extract for 24 h and 48 h. Extract concentrations
required for 50% inhibition of growth (IC50) were 0.72 mg/mL and
0.41mg/mL for 24 and 48 h of treatment, respectively (Table 4). The
concentrations required for 80% of growth inhibition (IC80) were
1.32 mg/mL and 0.80 mg/mL for 24 h and 48 h, respectively. These
results are consistent with two previously published showing that
M. giganteus methanolic extract displays cytotoxicity against hu-
man breast carcinoma cells MCF-7 (with similar range of IC50
concentrations) and against murine Lewis lung carcinoma cell line
3LL (Karaman et al., 2009; Tomasi, Lohezic-Le Devehat, Sauleau,
Bezivin,& Boustie, 2004). Methanolic extract ofM.giganteus did not
cause 50% inhibition of growth (IC50) of normal ﬁbroblast cell line
MRC-5, even at the highest concentration tested (1.6 mg/mL,
Table 4).assay). Cells migration was quantiﬁed 20 h after scratching in constant presence of
h at 0 h was set as 100%. Results were presented as the means ± SEM of at least three
D.S. Stojkovic et al. / LWT - Food Science and Technology 79 (2017) 454e462 461These results suggest the presence of bioactive compounds that
impair cell growth in the analyzed extract. The identiﬁed phenolic
acids could be, at least partly, responsible for this property. p-
Coumaric acid, most abundant phenolic component ofM. giganteus
methanolic extract, was previously shown to inhibit proliferation
and induce apoptosis of colorectal adenocarcinoma cell lines (HCT-
15 and HT-29) (Jaganathan, Supriyanto, &Mandal, 2013). Cytotoxic
activity on several malignant cell lines was also demonstrated for
cinnamic acid and its derivatives (Sova et al., 2013).
3.2.4. Induction of apoptosis of HeLa cells
First we have observed morphological changes in HeLa cells
nuclei after treatment with M. giganteus extract using double
staining with DAPI and PI. Cells treated withM. giganteus extract for
24 or 48 h exhibited typical features of apoptosis such as nuclear
condensation, fragmentation and formation of apoptotic bodies
(Fig. 2A). Cells in early apoptosis have highly condensed chromatin
that is characterized by more intense blue ﬂuorescence compared
to the nuclei of healthy cells, while cells in late apoptosis/necrosis
have lost the integrity of their plasma membranes and their
condensed/fragmented chromatin is characterized by bright red
ﬂuorescence. Observed morphological changes suggest that
mechanism underlying inhibition of cell growth by M. giganteus
extract relies on induction of apoptosis. This mode of action has
been demonstrated previously for many mushroom extracts and
their bioactive principles (Popovic et al., 2013).
These results were conﬁrmed by ﬂow cytometry (Fig. 2B and C).
Obtained results suggested that M. giganteus methanolic extract
induced early apoptosis in HeLa cells (Annexinþ/PI). Based on
three independent experiments the percentage of cells in early
apoptosis raised to 17% compared to control cells treated with
vehicle only (Fig. 2C). At the same time, the low percentage of cells
with necrosis (Annexin/PIþ) and late apoptosis (Annexinþ/PIþ)
remained unchanged. Taken together, these results suggest that
M. giganteus extract induced apoptosis of HeLa cells.
3.2.5. The effect on migratory potential of HeLa cells
Since the ability of cancer cells to migrate is closely associated
with their capacity to colonize distant organs, we tested migratory
potential of HeLa cells, upon treatment with M. giganteus extract,
using wound scratch assays. We detected that treated HeLa cells
were slower in closing the scratched area than control cells (Fig. 3),
showing that M. giganteus extract exhibits not only cytotoxic, but
also antimigratory effect on HeLa cells.
Antimigratory potential of mushroom's extracts has been re-
ported for other classes like Fomitopsis pinicolawhich belongs to the
Basidiomycota fungal class that could inhibit the migration of colon
cancer cell line SW-480 (Wang et al., 2014), or Ganoderma lucidum
that exerts strong antimigratory effect on ovarian cancer cell lines
(Zhao et al., 2011). This is the ﬁrst report presenting antimigratory
potential of M. giganteus extract on cancer cells in vitro.
4. Conclusions
Chemical composition analysis of M. giganteus methanolic
extract revealed the presence of bioactive compounds (all tocoph-
erol isoforms, ﬁve organic and three phenolic acids) along with
carbohydrates, fatty acids and proteins. Trehalose was identiﬁed as
the predominant free sugar. Polyunsaturated fatty acids predomi-
nated over monounsaturated and saturated fatty acids, highlighting
linoleic acid as the most dominant one. M. giganteus is a natural
source of agents exhibiting antioxidant, antimicrobial and anti-
tumor activities highlighting this species as a valuable dietary
supplement in chemoprevention. Importantly, M. giganteus extract
was not toxic for zebraﬁsh embryos indicating its biosafety andpotential for further applications in food or pharmaceutical
industry.
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